Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.3 - WILLIS TOWERS WATSON PLC - Amendment

3rd Feb 2021 07:00

 

Ap19

FORM 8.3 Amendment to Purchase

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1)Barclays PLC.
Company dealt inWILLIS TOWERS WATSON PLC
Class of relevant security to which theORD
dealings being disclosed relate (Note 2)
Date of dealing29 January 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security:ORD
LongShort
Number(%)Number(%)

(1)

Relevant securities

2,363,884

1.83%

605,662

0.47%

 

 

 

 

(2)

Derivatives (other than options):

 

 

 

 

273,127

0.21%

455,399

0.35%

 

 

 

 

(3)

Options and agreements to

 

 

 

 

purchase/sell:

6,000

0.00%

6,000

0.00%

 

 

 

 

TOTAL:

 

 

 

 

2,643,011

2.05%

1,067,061

0.83%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security:

Long

Short

 

Number

 

(%)

Number

 

(%)

(1) Relevant securities

 

 

 

(2) Derivatives (other than options)

 

 

 

(3) Options and agreements to purchase/sell

 

 

Total

 

 

 

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/saleNumber of relevant securitiesPrice per unit
Purchase

1

204.2500 USD
Purchase

3

203.6333 USD
Purchase

4

203.1800 USD
Purchase

21

203.5326 USD
Purchase

23

203.7078 USD
Purchase

29

203.8400 USD
Purchase

100

203.9900 USD
Purchase

400

204.9175 USD
Purchase

584

203.3138 USD
Purchase

1,023

203.8826 USD
Purchase

1,038

203.9549 USD
Purchase

3,527

204.0332 USD
Purchase

5,698

204.1155 USD
Purchase

7,950

204.0525 USD
Purchase

12,066

203.1712 USD
Purchase

15,301

203.9371 USD
Purchase

27,610

203.9738 USD
Purchase

41,231

202.9400 USD
Sale

1

202.4400 USD
Sale

1

204.0400 USD
Sale

1

203.6100 USD
Sale

3

203.7233 USD
Sale

5

203.7000 USD
Sale

7

203.5364 USD
Sale

9

203.5766 USD
Sale

13

203.7484 USD
Sale

20

203.9100 USD
Sale

100

204.0900 USD
Sale

181

203.9355 USD
Sale

202

203.7050 USD
Sale

218

204.5509 USD
Sale

230

204.0417 USD
Sale

300

204.0800 USD
Sale

305

203.9860 USD
Sale

370

203.8124 USD
Sale

400

204.9175 USD
Sale

500

203.5750 USD
Sale

502

203.8123 USD
Sale

584

203.3138 USD
Sale

600

205.0937 USD
Sale

833

203.9142 USD
Sale

957

204.1202 USD
Sale

961

203.8843 USD
Sale

1,164

204.0811 USD
Sale

1,173

203.6912 USD
Sale

1,406

204.1804 USD
Sale

1,500

204.1043 USD
Sale

1,700

203.9608 USD
Sale

1,876

203.9013 USD
Sale

1,900

203.6752 USD
Sale

1,984

203.8424 USD
Sale

2,100

203.8819 USD
Sale

2,286

204.0384 USD
Sale

2,428

203.8656 USD
Sale

3,415

204.1069 USD
Sale

4,143

203.8810 USD
Sale

4,729

203.7127 USD
Sale

5,133

204.2172 USD
Sale

6,462

202.9405 USD
Sale

7,023

203.9677 USD
Sale

11,093

204.1103 USD
Sale

13,018

203.2267 USD
Sale

33,857

202.9400 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD

Nature of transaction

(Note 6)

Number of relevant securities

(Note 7)

Price per unit

(Note 5)

 

 

 

 

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option

Writing, selling, purchasing, varying etc.

Number of securities to which the option relates (Note 7)

Exercise price

Type, e.g. American, European etc.

Expiry date

Option money paid/received per unit (Note 5)

 

 

 

 

 

 

 

(ii) Exercising

Product name,

e.g. call option

Number of securities

Exercise price per unit (Note 5)

 

 

 

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)

Details

Price per unit

(if applicable) (Note 5)

 

 

 

 

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached?YES
Date of disclosure:

3 Feb 2021

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL

ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS
Product nameWritten orNumber ofExerciseTypeExpiry
purchasedrelevant securitiespricedate
to which the option
or derivative
relates
Call OptionsPurchased

6,000

220.0000

AmericanJul 16, 2021
Put OptionsPurchased

-6,000

200.0000

AmericanJul 16, 2021

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20210202006246/en/

Copyright Business Wire 2021


Related Shares:

Barclays
FTSE 100 Latest
Value8,816.05
Change-21.86